$HIPH -Press Release out! Trademark filled for its #CBD

New Post Public Reply Private Reply Replies (0) Message Board
stockstein
96
$HIPH -Press Release out! Trademark filled for its #CBD beverage LALPINA HYDRO CBD that goes on sale Aug 27

American Premium Water Corp. (OTC:HIPH) Files IP Protection in Advance of CBD Beverage Launch on August 27, 2018Press Release | 08/08/2018

PLAYA VISTA, Calif., Aug. 08, 2018 (GLOBE NEWSWIRE) -- American Premium Water Corporation (OTC Pink:HIPH) (the “Company”) announces that the Company filed for intellectual property protection on August 7th in advance of the launch of LALPINA Hydro CBD on August 27th. This step will ensure the Company is safeguarded when it releases its market front running CBD products later this month. The Company also named David Schechtmann as President.

Ryan Fishoff, CEO of American Premium Water Corporation, commented, “The Company has filed the IP for LALPINA CBD products. This is another necessary and critical step in advance of our launch of LALPINA Hydro CBD. We want to take all necessary steps to protect our first to market advantage. Like I said last month when we announced the launch date, I cannot wait to begin the next phase of this process to begin selling this product. From conversations with industry leaders and investors, there is so much interest in the space, and it’s quite staggering how much the CBD market is growing on a weekly and monthly basis. I am happy to announce that the Company has formally added David Schechtmann as President of American Premium Water Corporation. His addition will be great for the company as we begin to ramp up the rollout of LALPINA Hydro CBD. He (David) will be a key asset with his legal background as we are in the process of evaluating several CBD related acquisitions. I am excited to work with David and I am very excited for the future holds for the Company in the near and long term.”

Mr. Schechtmann, who has advised the Company since shortly after its inception as American Premium Water in 2013, is a licensed lawyer in two states. Mr. Schechtmann will begin his position effective August 9th. In addition to his time advising the Company over the past five years, he has worked in a number of branding and social capabilities. His experience and abilities are a tremendous addition to the Company’s management team. Mr. Schechtmann will report directly to CEO Ryan Fishoff.

“David is a tremendous addition to the management team. I am so happy to have him aboard. He will be a tremendous asset to the Company and myself, as we continue to move forward with the strategy that I outlined earlier this year. Adding David will increase the Company’s bandwidth to evaluate more acquisitions and continue to dedicate resources to the Company’s existing brands (LALPINA, Gents, Worthy, FashionCoinX) and continue to grow them. Right now as we prepare for the launch of LALPINA CBD, David’s hire will free me up to focus on the ramp of this product that is extremely critical to shareholder value,” added Mr. Fishoff.

The Company first announced its creation of a CBD prototype during the week of Super Bowl LII. Delivering the CBD prototype was one of the keystone achievements of Mr. Fishoff’s first year as CEO, and an integral part of the “Brand. Luxury. Lifestyle” strategy that was released to the investor community earlier this year. CBD, the natural phytocannabinoid extracted from cannabis, is extracted from the stalk of a hemp plant and must have less than 0.3 percent THC, which allows it to be sold in states where cannabis isn’t legal. CBD can be as an all-natural alternative to opioids. Studies have shown that CBD can be a natural remedy for such ailments as asthma, insomnia, anxiety, depression, arthritis, among others maladies. The CBD market, which generated $820 million of sales in 2017, is projected to grow at 54% CAGR to $3 billion in 2020 according to Greenware Advisors, a large subsector in the overall $25 billion cannabis industry.

For a more in-depth look at American Premium’s long-term strategy, please view this interview that Mr. Fishoff conducted on the floor of the NASDAQ exchange with former Wall Street Journal reporter, Jane King:
https://www.youtube.com/watch?time_continue=8...AfhDCjQbdI

American Premium Water Corp. is the public holding trading company that owns LALPINA HYDRO, LALPINA HYDRO CBD, Gents, Worthy, and FashionCoinX.

Please follow us on our social media outlets listed below:

@americanpremium
@lalpinabrands
@GentsCo
@FashionCoinX
#Gentsco
#lalpinahydrogen

For more information on American Premium Water Corporation / HIPH, go to:
http://www.lalpinahydrogen.com/investor-page.html

Gents
The New York-based Gents is a producer of luxury hats and other fine accessories and apparel. Their line is carried in over 200 retail outlets internationally, including Bloomingdale’s (NYSE:M), Nordstrom (NYSE:JWN), and Saks Fifth Avenue (TSE:HBC).

Visit the website below to learn more:
https://www.gentsco.com

@GentsCo
#GentsCo
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fluence Energy Hits Legal Snag: Investors Called to Act

Updated Category News Views 79

Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 421

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 134

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Updated Category News Views 72

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 140

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 93

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 149

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 312

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 242

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 87

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading

Top 5 Most Recently Viewed Articles

Nippon Express Europe Partners with Formag for Logistics Support

Updated Category News Views 213

Nippon Express Europe and Formag Form New Logistics Partnership Nippon Express Europe GmbH, part of NIPPON EXPRESS HOLDINGS, INC., has recently signed a cooperation agreement with Ukrainian logistics provider, Formag-Kiev. This significant collaboration aims to provide essential logistical support for the reconstruction of Ukraine. Commitment to Ukrainian Reconstruction...

Continue Reading
Escalating Legal Action Over LIBRA Token Sparks Controversy

Updated Category News Views 265

Legal Developments in the LIBRA Token Case A prominent Argentine lawyer has made headlines by calling for global law enforcement to apprehend a cryptocurrency figure involved in the LIBRA token controversy. Details of the Extradition Request Gregorio Dalbon, known for his defense work with former Argentine President Cristina Fernandez in a prominent corruption matter, has...

Continue Reading
Tesla Prevails in Motion to Dismiss Racial Bias Lawsuit

Updated Category News Views 230

Tesla's Legal Victory Against Racial Bias Allegations Under the direction of Elon Musk, Tesla Inc. (NASDAQ: TSLA) has successfully overturned a significant class action lawsuit that was brought forth by more than 6,000 African American workers. These workers alleged racial discrimination at Tesla's Fremont assembly plant. This ruling is a key moment in the ongoing...

Continue Reading
ZenaTech Unveils Specialized AI Hub to Bolster US Defense Tactics

Updated Category News Views 100

ZenaTech Launches Innovative AI Development Center Vancouver, British Columbia – ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) has taken a significant stride toward advancing artificial intelligence technologies by establishing Zena AI, Inc. This new AI Development Center will focus on crafting specialized AI solutions tailored for defense and homeland security...

Continue Reading
Investors Reminded of Action Timeline Against ICON plc - ICLR

Updated Category News Views 172

Understanding the Legal Proceedings Against ICON plc In an important reminder for shareholders, Kahn Swick & Foti, LLC is emphasizing the critical timeline for investors affected by losses from their holdings in ICON plc (NASDAQ: ICLR). The firm, led by former Louisiana Attorney General Charles C. Foti, Jr., is urging investors who incurred losses exceeding $100,000 to...

Continue Reading